Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.
2.

The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.

Qiu L, Chen Y, Wu J.

Hell J Nucl Med. 2013 Sep-Dec;16(3):230-6. doi: 10.1967/s0024499100091. Epub 2013 Oct 2. Review.

PMID:
24137577
3.

Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.

Facey K, Bradbury I, Laking G, Payne E.

Health Technol Assess. 2007 Oct;11(44):iii-iv, xi-267. Review.

5.

Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.

Even-Sapir E, Lievshitz G, Perry C, Herishanu Y, Lerman H, Metser U.

Radiol Clin North Am. 2007 Jul;45(4):697-709, vii. Review.

PMID:
17706534
6.

FDG PET-CT in the management of primary breast lymphoma.

Santra A, Kumar R, Reddy R, Halanaik D, Kumar R, Bal CS, Malhotra A.

Clin Nucl Med. 2009 Dec;34(12):848-53. doi: 10.1097/RLU.0b013e3181becdfc. Review.

PMID:
20139815
7.

FDG-PET/CT in lymphoma.

Juweid ME.

Methods Mol Biol. 2011;727:1-19. doi: 10.1007/978-1-61779-062-1_1. Review.

PMID:
21331925
8.

FDG PET and PET/CT in the Management of Pediatric Lymphoma Patients.

Cheng G, Servaes S, Alavi A, Zhuang H.

PET Clin. 2008 Oct;3(4):621-34. doi: 10.1016/j.cpet.2009.04.004. Epub 2009 Jul 25. Review.

PMID:
27156825
Items per page

Supplemental Content

Write to the Help Desk